It becomes difficult when diabetic patients incur infections, because not all antibiotics work on all patients and when their wounds are infected, there is always the threat that limbs have to be amputated.

Now, as suggested by a new research from the collaborative team of University of Washington, Rosalind Franklin University of Medicine and Science, Merck Laboratories, and Mount Sinai School of Medicine, specific laboratory and clinical tests can predict outcome of antibiotic therapy for infections in persons with diabetes.

According to Dr. David G. Armstrong, Professor of Surgery at Scholl's Center for Lower Extremity Ambulatory Research (CLEAR) at Rosalind Franklin University:

"This study is unique in a couple of ways. It comes from the largest-ever clinical trial of antibiotics for this type of infection, and it used very specific, day-to-day measures that can be done in any hospital, world wide."

Study findings such as this help doctors to carry on with better diabetes care management and were reported in the International Wound Journal.

To find out more about the said clinical trial, click here.

Source: Medical News Today